XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
May 31, 2023
May 31, 2022
Operating Activities:    
Net income $ 93,824 $ 81,249
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 53,264 50,258
Allowance for doubtful accounts (46) 10
Loss on sale of property and equipment 295 881
Deferred income taxes (723) (3,241)
Equity in losses of unconsolidated affiliates 63 6
Stock-based compensation 13,522 12,678
Change in operating assets and liabilities:    
Receivables, prepaid expenses and other current assets, non-current assets, accrued salaries and benefits, deferred membership income and other accruals (5,229) (16,133)
Merchandise inventories 21,831 (71,257)
Accounts payable 7,880 9,860
Net cash provided by operating activities 184,681 64,311
Investing Activities:    
Proceeds from the disposal of Aeropost, net of divested cash 0 4,959
Additions to property and equipment (96,557) (98,562)
Purchases of short-term investments (123,317) (22,442)
Proceeds from settlements of short-term investments 21,842 53,058
Proceeds from settlements of long-term investments 0 1,486
Proceeds from disposal of property and equipment 218 97
Net cash used in investing activities (197,814) (61,404)
Financing Activities:    
Proceeds from long-term bank borrowings 38,712 30,633
Repayment of long-term bank borrowings (31,407) (17,804)
Proceeds from short-term bank borrowings 3,156 22,313
Repayment of short-term bank borrowings (3,229) (6,505)
Cash dividend payments (14,290) (13,275)
Purchase of treasury stock (5,993) (3,997)
Net cash provided by (used in) financing activities (13,051) 11,365
Effect of exchange rate changes on cash and cash equivalents and restricted cash 11,183 (7,034)
Net increase (decrease) in cash, cash equivalents (15,001) 7,238
Cash, cash equivalents and restricted cash at beginning of period 251,373 215,479
Cash, cash equivalents and restricted cash at end of period 236,372 222,717
Supplemental disclosure of noncash investing activities:    
Capital expenditures accrued, but not yet paid 4,052 1,456
Dividends declared but not yet paid 14,426 13,430
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 222,668 207,528
Short-term restricted cash 2,965 2,986
Long-term restricted cash 10,739 12,203
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows $ 236,372 $ 222,717